Characteristic of Cyclodextrins: Their Role and Use in the Pharmaceutical Technology.

Current Drug Targets
Malwina LachowiczMichał Kołodziejczyk

Abstract

About 40% of newly-discovered entities are poorly soluble in water, and this may be an obstacle in the creation of new drugs. To address this problem, the present review article examines the structure and properties of cyclodextrins and the formation and potential uses of drug - cyclodextrin inclusion complexes. Cyclodextrins are cyclic oligosaccharides containing six or more D-(+)- glucopyranose units linked by α-1,4-glycosidic bonds, which are characterized by a favourable toxicological profile, low local toxicity and low mucous and eye irritability; they are virtually non-toxic when administered orally. They can be incorporated in the formulation of new drugs in their natural form (α-, β-, γ-cyclodextrin) or as chemically-modified derivatives. They may also be used as an excipient in drugs delivered by oral, ocular, dermal, nasal and rectal routes, as described in the present paper. Cyclodextrins are promising compounds with many beneficial properties, and their use may be increasingly profitable for pharmaceutical scientists.

References

Jun 9, 2005·International Journal of Pharmaceutics·Francesca MaestrelliPaola Mura
Jul 16, 2005·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Sarah Gould, Robert C Scott
Nov 25, 2005·Current Drug Delivery·Heather A E Benson
Dec 6, 2005·Carbohydrate Research·Edvaldo SabadiniFernanda do Carmo Egídio
Dec 16, 2005·AAPS PharmSciTech·Rajeswari ChallaR K Khar
Sep 5, 2006·Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy·Carolina JullianClaudio Olea-Azar
Dec 2, 2006·International Journal of Pharmaceutics·Thorsteinn Loftsson, Dominique Duchêne
Jan 24, 2007·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Seoung Wook JunSung-Joo Hwang
Feb 13, 2007·Journal of Pharmaceutical and Biomedical Analysis·Santo ScaliaValentina Iannuccelli
Jun 5, 2007·European Journal of Medicinal Chemistry·Gladys E GraneroMarcela R Longhi
Jul 3, 2007·Advanced Drug Delivery Reviews·Marcus E Brewster, Thorsteinn Loftsson
Jul 17, 2007·Journal of Pharmaceutical Sciences·Thorsteinn LoftssonFífa Konrádsdóttir
Sep 11, 2007·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Krzysztof Cal, Katarzyna Centkowska
Sep 20, 2007·Acta Pharmaceutica : a Quarterly Journal of Croatian Pharmaceutical Society and Slovenian Pharmaceutical Society, Dealing with All Branches of Pharmacy and Allied Sciences·Haresh M PatelVijay K Parmar
Sep 25, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Rebecca L CarrierImran Ahmed
Nov 21, 2007·International Journal of Pharmaceutics·G S Jadhav, P R Vavia
Nov 27, 2007·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Daniele R de AraujoEneida de Paula
Dec 28, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Laura MatilainenKristiina Järvinen
Feb 12, 2008·Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy·Carolina JullianClaudio Olea-Azar
Feb 16, 2008·Drug Discovery Today·Sanjeeb K SahooS Krishnakumar
Mar 14, 2008·Toxicologic Pathology·Valentino J Stella, Quanren He
Jul 29, 2008·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Shaimaa M Badr-EldinMahmoud M Ghorab
Sep 2, 2008·Pharmaceutical Research·Ripal GaudanaAshim K Mitra
Oct 23, 2008·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Ahmed AbdallaKarsten Mäder
Jan 2, 2009·Biomacromolecules·Desirée Teijeiro-OsorioMaría José Alonso
Feb 19, 2009·Anaesthesia·L H D J Booij
Sep 3, 2009·Biotechnology and Bioengineering·Ece Dilber GamsizRebecca Lyn Carrier
Sep 19, 2009·Applied Microbiology and Biotechnology·Hans LeemhuisLubbert Dijkhuizen
Dec 8, 2009·International Journal of Pharmaceutics·Martin MessnerThorsteinn Loftsson
May 26, 2010·Journal of Drug Targeting·A L Laza-KnoerrP Couvreur
Jul 14, 2010·Journal of Pharmaceutical and Biomedical Analysis·Shan-Yang LinMing-Thau Sheu
Oct 12, 2010·Carbohydrate Research·Claudia GarneroMarcela Longhi
Nov 3, 2010·The Journal of Pharmacy and Pharmacology·Thorsteinn Loftsson, Marcus E Brewster
Mar 5, 2011·Journal of Pharmaceutical Sciences·Nao OnoKaneto Uekama
Apr 1, 2010·Journal of Pharmacy & Bioallied Sciences·Gaurav TiwariAwani K Rai
Aug 11, 2011·The Journal of Pharmacy and Pharmacology·Thorsteinn Loftsson, Marcus E Brewster
Sep 8, 2011·Journal of Young Pharmacists : JYP·A GhoshT Ghosh
Feb 16, 2012·Journal of Pharmaceutical Sciences·Thorsteinn Loftsson, Marcus E Brewster
Apr 3, 2012·Pharmacology & Therapeutics·Stanislas Grassin-DelylePhilippe Devillier

❮ Previous
Next ❯

Citations

Oct 28, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jules César BayihaMarie-Paule Mingeot-Leclercq

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Annales pharmaceutiques françaises
F Fauvelle, J C Debouzy
Die Naturwissenschaften
F Cramer, H Hettler
Expert Opinion on Drug Delivery
Thorsteinn LoftssonTomi Järvinen
© 2022 Meta ULC. All rights reserved